Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Blood|January 29, 2014
Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasmsNeha Bhagwat, Priya Koppikar, Matthew Keller, et al.
The New England Journal of Medicine|November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatmentMargaret K Callahan, Raajit Rampal, James J Harding, et al.
Haematologica|September 23, 2021
Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopeniaSrdan Verstovsek, Ruben Mesa, Moshe Talpaz, et al.
Hematological Oncology|June 28, 2020
Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignanciesTariq I Mughal, Naveen Pemmaraju, Bethan Psaila, et al.
Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Leukemia & Lymphoma|October 21, 2014
Novel insights into the biology and treatment of chronic myeloproliferative neoplasmsTariq I Mughal, Tiziano Barbui, Omar Abdel-Wahab, et al.
Human Molecular Genetics|April 29, 2005
CADASIL mutations impair Notch3 glycosylation by FringeJoseph F Arboleda-Velasquez, Raajit Rampal, Erik Fung, et al.
Blood Advances|March 29, 2019
A scale for patient-reported symptom assessment for patients with Erdheim-Chester diseaseEli L Diamond, Anne S Reiner, Justin J Buthorn, et al.
Pageof 8